Ian Mortimer $XENE SEC Form 4 Insider Trading

Ian Mortimer has filed a total of 25 insider trades in $XENE since 2021. Their most recent trade was a sale of 7,308 shares, made on Mar 13, 2026. Their largest trade was a sale of 65,000 shares, made on Mar 09, 2026. We estimate that they now own 125,000 shares of $XENE, worth an estimated $1.2 million.

Insider Trading at $XENE

There have been a total of 99 insider trades reported at $XENE since 2021, with 4,700 shares purchased and 1.2 million shares sold. The most active insider traders in $XENE stock have been Ian Mortimer, Sherrington Robin, and James R. Empfield. The most recent trade was a sale of 1,410 shares reported by CHRISTOPHER JOHN KENNEY (Chief Medical Officer), made on Mar 13, 2026.

$XENE Executives and Stock Owners with Insider Trades

• Ian Mortimer, PRESIDENT & CEO

• Sherrington Robin, EVP, Strategy & Innovation

• James R. Empfield, EVP, Drug Discovery

• Christopher John Kenney, Chief Medical Officer

• Sherry Aulin, Chief Financial Officer

• Andrea Difabio, Chief Legal Officer

• Ian Mortimer, PRESIDENT, CEO & INTERIM CFO

• Seggern Christopher Von, Chief Commercial Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.